Authors:
Ruiz, L
Negredo, E
Domingo, P
Paredes, R
Francia, E
Balague, M
Gel, S
Bonjoch, A
Fumaz, CR
Johnston, S
Romeu, J
Lange, J
Clotet, B
Citation: L. Ruiz et al., Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy, J ACQ IMM D, 27(3), 2001, pp. 229-236
Authors:
Negredo, E
Domingo, P
Sambeat, MA
Rabella, N
Vazquez, G
Citation: E. Negredo et al., Effect of pneumococcal vaccine on plasma HIV-1 RNA of stable patients undergoing effective highly active antiretroviral therapy, EUR J CL M, 20(4), 2001, pp. 287-288
Authors:
Tuldra, A
Fumaz, CR
Ferrer, MJ
Bayes, R
Arno, A
Balague, M
Bonjoch, A
Jou, A
Negredo, E
Paredes, R
Ruiz, L
Romeu, J
Sirera, G
Tural, C
Burger, D
Clotet, B
Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228
Authors:
Lopez-Contreras, J
Blanco-Vaca, F
Borras, X
Carreras, F
Pons-Llado, G
Gallego, F
Sole, MJ
Cirera, S
Benet, MT
Negredo, E
Roca-Cusachs, A
Citation: J. Lopez-contreras et al., Usefulness of the I/D angiotensin-converting enzyme genotype for detectingthe risk of left ventricular hypertrophy in pharmacologically treated hypertensive men, J HUM HYPER, 14(5), 2000, pp. 327-331
Authors:
Ruiz, L
Martinez-Picado, J
Romeu, J
Paredes, R
Zayat, MK
Marfil, S
Negredo, E
Sirera, G
Tural, C
Clotet, B
Citation: L. Ruiz et al., Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS, 14(4), 2000, pp. 397-403
Authors:
Paredes, R
Puig, T
Arno, A
Negredo, E
Balague, M
Bonjoch, A
Jou, A
Tuldra, A
Tural, C
Sirera, G
Veny, A
Romeu, J
Ruiz, L
Clotet, B
Citation: R. Paredes et al., High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response, J ACQ IMM D, 22(2), 1999, pp. 132-138
Authors:
Negredo, E
Paredes, R
Bonjoch, A
Tuldra, A
Fumaz, CR
Gel, S
Garces, B
Johnston, S
Arno, A
Balague, M
Jou, A
Tural, C
Sirera, G
Romeu, J
Cruz, L
Francia, E
Domingo, P
Arrizabalaga, J
Ruiz, I
Arribas, JR
Ruiz, L
Clotet, B
Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28
Authors:
Fuster, M
Negredo, E
Cadafalch, J
Domingo, P
Illa, I
Clave, P
Citation: M. Fuster et al., HIV-associated polymyositis with life-threatening myocardial and esophageal involvement, ARCH IN MED, 159(9), 1999, pp. 1012-1012
Authors:
Negredo, E
Domingo, P
Sambeat, MA
Rabella, N
Vazquez, G
Citation: E. Negredo et al., Influence at coinfection with hepatitis viruses on human immunodeficiency plasma viral load, ARCH IN MED, 159(19), 1999, pp. 2367-2368
Citation: L. Ruiz et al., Benefit of switching the Protease Inhibitor (PI) by nevirapine in PI - experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL). Interim analysis at 6 months of follw-up, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 49-54